<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="308233">
  <stage>Registered</stage>
  <submitdate>16/07/2009</submitdate>
  <approvaldate>7/08/2009</approvaldate>
  <actrnumber>ACTRN12609000674235</actrnumber>
  <trial_identification>
    <studytitle>Trial of swine influenza vaccine in healthy adults</studytitle>
    <scientifictitle>A  randomised, controlled, study in healthy adults to evaluate the safety and immunogenicity of an adjuvanted  recombinant 2009 H1N1 pandemic swine influenza vaccine</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>FLU005</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Swine influenza</healthcondition>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Other infectious diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Recombinant 2009 H1 haemagglutinin in Advax-adjuvanted vaccine -Subjects will be randomised to receive one of three doses of haemagglutinin ranging from 5, 15 and 45 micrograms</interventions>
    <comparator>Recombinant 2009 H1 haemagglutinin 45 microgram dose without adjuvant will be the control treatment</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Seroconversion to 2009 H1N1 as assessed by haemagglutination inhibition assay</outcome>
      <timepoint>3 weeks post first and second vaccination</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Safety as assessed by frequency of vaccine-related and total adverse events</outcome>
      <timepoint>3 weeks post first and second vaccination</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Anti-swine flu T-cell responses as assessed by T-cell recall responses</outcome>
      <timepoint>3 weeks post first and second vaccination</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Vaccine tolerability as assessed by visual analogue pain score</outcome>
      <timepoint>At time of administration of first and second vaccination</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy adults</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Pregnancy
Lactation</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1 / Phase 2</phase>
    <anticipatedstartdate>20/07/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>300</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Vaxine Pty Ltd</primarysponsorname>
    <primarysponsoraddress>Flinders Medical Centre
Flinders Drive
Bedford Park
SA 5042</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Flinders Medical Centre</fundingname>
      <fundingaddress>Flinders Drive
Bedford Park
SA 5042</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This is the first human study of a novel swine flu vaccine that is designed to identify the optimum  dose of vaccine, the optimum number of doses and whether or not an adjuvant is required to provide maximal protection against swine flu</summary>
    <trialwebsite>www.vaxine.com.au/swine_flu</trialwebsite>
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Flinders Human Research Ethics Committee</ethicname>
      <ethicaddress>Flinders medical Centre
Flinders Drive
Bedford Park
SA 5042</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Nikolai Petrovsky</name>
      <address>Flinders Medical Centre
Flinders Drive
Bedford Park
SA 5042
Australia</address>
      <phone>+61 8 82044572</phone>
      <fax>+61 8 82045987</fax>
      <email>nikolai.petrovsky@flinders.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Nikolai Petrovsky</name>
      <address>Flinders Medical Centre
Flinders Drive
Bedford Park
SA 5042</address>
      <phone>+61 8 82044572</phone>
      <fax>+61 8 82045987</fax>
      <email>nikolai.petrovsky@flinders.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Nikolai Petrovsky</name>
      <address>Flinders Medical Centre
Flinders Drive
Bedford Park
SA 5042
Australia</address>
      <phone>+61 8 82044572</phone>
      <fax>+61 8 82045987</fax>
      <email>nikolai.petrovsky@flinders.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Dimitar Sajkov</name>
      <address>Flinders Medical Centre
Flinders Drive
Bedford Park
Adelaide
Australia 5042</address>
      <phone>+61882044572</phone>
      <fax>+61 8 82045987</fax>
      <email>dimitar.sajkov@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>